Table 2 Baseline symptoms.
| Variable | Ketoprofen | Diclofenac | p Values |
|---|---|---|---|
| Number of patients | n = 114 | n = 109 | |
| Pain with ADLs (mm), Mean | 72.8 | 71.1 | 0.35* |
| SD | 13.29 | 14.40 | |
| Range | 45–100 | 40–99.9 | |
| Baseline swelling | 0.88† | ||
| Absent | 45 (39.5%) | 38 (34.9%) | |
| Mild | 40 (35.1%) | 42 (28.5%) | |
| Moderate | 25 (21.9%) | 26 (23.9%) | |
| Severe | 4 (3.5%) | 3 (2.8%) | |
| Muscle rigidity or stiffness | 0.52† | ||
| Absent | 48 (42.1%) | 36 (33.0%) | |
| Mild | 31 (27.2%) | 37 (33.9%) | |
| Moderate | 31 (27.2%) | 31 (28.4%) | |
| Severe | 4 (3.5%) | 5 (4.6%) | |
| Bruise | |||
| Absent | 82 (71.9%) | 73 (67.6%) | 0.51† |
| Mild | 16 (14.0%) | 13 (12.0%) | |
| Moderate | 11 (9.6%) | 18 (16.7%) | |
| Severe | 5 (4.4%) | 4 (3.7%) | |
| Functional disability | |||
| Absent | 6 (5.3%) | 6 (5.5%) | 0.42† |
| Mild | 27 (23.7%) | 24 (22.0%) | |
| Moderate | 68 (59.6%) | 59 (54.1%) | |
| Severe | 13 (11.4%) | 20 (18.3%) | |
| Full passive motion | |||
| Absent | 6 (5.3%) | 7 (6.4%) | 0.13† |
| Mild | 29 (25.4%) | 21 (19.3%) | |
| Moderate | 61 (53.5%) | 50 (45.9%) | |
| Severe | 18 (15.8%) | 31 (28.4%) | |
| Passive isometric contraction | |||
| Absent | 18 (15.8%) | 14 (12.8%) | 0.07† |
| Mild | 49 (43.0%) | 37 (33.9%) | |
| Moderate | 39 (34.2%) | 44 (40.4%) | |
| Severe | 8 (7.0%) | 14 (12.9%) | |
| Pain on pressure | |||
| Absent | 1 (0.9%) | 1 (0.9%) | 0.76† |
| Mild | 17 (14.9%) | 13 (11.9%) | |
| Moderate | 55 (48.2%) | 48 (44.0%) | |
| Severe | 41 (36.0%) | 47 (43.1%) |
ADL, activities of daily living.
Values are represented as n (%) unless otherwise specified.
*p Values for treatment comparisons from an analysis of variance.
†p Values for treatment comparisons from a χ2 test.